Sotalol and mexiletine: combination of rate-dependent electrophysiological effects.
The rate-dependent electrophysiological effects of sotalol (30 microM), mexiletine (10 and 18 microM), and their coadministration were examined in isolated dog cardiac Purkinje fibers following abrupt changes in pacing cycle length. Combination of 30 microM sotalol with 10 microM mexiletine significantly lengthened premature action potential durations at diastolic intervals of less than 50 ms while the basic action potential duration evoked at a stimulus frequency of 2 Hz was not affected. This effect on the premature action potential duration was attenuated when the higher mexiletine concentration (18 microM) was coadministered with sotalol. The fast time constant for restitution of the action potential duration was significantly slowed by either combination. Coadministration of sotalol and mexiletine, like mexiletine alone, produced a rate-dependent depression of Vmax that displayed a second slow time component during recovery. This slow component for recovery of Vmax was not distinguished in the absence of drug or in the presence of sotalol alone. Sotalol-induced lengthening of the action potential duration observed at slow pacing frequencies was also attenuated by addition of mexiletine; and, under these conditions, Purkinje fiber early afterdepolarizations were prevented. In addition, the range of premature action potential durations was significantly decreased by mexiletine and by the combination, while sotalol alone increased this range slightly. These results indicate that coadministration of sotalol and mexiletine may provide beneficial electrophysiological effects expected to provide enhanced antiarrhythmic efficacy and fewer proarrhythmic complications in patients.
Varró
A
A
Department of Pediatrics, University of Cincinnati College of Medicine, Ohio.
Lathrop
D A
DA
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D003971:Diastole / Q000187:drug effects; D004285:Dogs; D004338:Drug Combinations; D004594:Electrophysiology; D005260:Female; D008297:Male; D008801:Mexiletine / Q000494:pharmacology*; D011690:Purkinje Fibers / Q000187:drug effects*; D013015:Sotalol / Q000494:pharmacology*
D004338:Drug Combinations; D008801:Mexiletine; D013015:Sotalol